Apalutamide will lessen the extent or impact of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with medications which can be CYP3A4 substrates may result in decrease publicity to those remedies. The administration of oral contraceptives to https://wymzya-fe07396.blogolize.com/buy-wymzya-fe-an-overview-69633128